Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-018026
Filing Date
2016-01-27
Accepted
2016-01-27 16:18:23
Documents
1
Period of Report
2016-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3058
  Complete submission text file 0001179110-16-018026.txt   4474
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Peacock Jonathan M (Reporting) CIK: 0001500241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 161365248

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations